Maxwell D Cummings Selected Research

Maxwell D Cummings Research Topics

4	Neoplasms (Cancer) 01/2018 - 01/2006
3	Infections 03/2014 - 11/2010
3	Hereditary Angioedemas 03/2008 - 06/2004
2	Reperfusion Injury 04/2006 - 06/2004
1	Body Weight (Weight, Body) 12/2020
1	Metabolic Diseases (Metabolic Disease) 12/2020
1	Chronic Pancreatitis 12/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018
1	Autoimmune Diseases (Autoimmune Disease) 08/2014
1	Fibrosis (Cirrhosis) 03/2014
1	Liver Diseases (Liver Disease) 03/2014
1	Blood-Borne Infections 03/2014
1	HIV Infections (HIV Infection) 08/2011
1	Hepatitis C 07/2009
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 03/2008

2	Serine Proteases (Serine Protease)IBA 12/2020 - 04/2006
2	Complement System Proteins (Complement)IBA 03/2008 - 06/2004
2	Proteins (Proteins, Gene)FDA Link 03/2008 - 10/2006
1	camostatIBA 12/2020
1	Blood Glucose (Blood Sugar)IBA 12/2020
1	EnteropeptidaseIBA 12/2020
1	LeptinIBA 12/2020
1	Interleukin-6 (Interleukin 6)IBA 12/2019
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2018
1	Malonyl Coenzyme A (Malonyl CoA)IBA 01/2018
1	PalmitatesIBA 01/2018
1	AcidsIBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 08/2014
1	InterferonsIBA 03/2014
1	Ribavirin (Virazole)FDA LinkGeneric 03/2014
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2012
1	Raltegravir Potassium FDA Link 08/2011
1	IntegrasesIBA 08/2011
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 07/2009
1	BenzodiazepinesIBA 07/2009
1	AntibodiesIBA 03/2008
1	Complement Inactivating AgentsIBA 03/2008
1	EnzymesIBA 10/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2006
1	Oncogene Proteins (Oncogene Protein)IBA 01/2006
1	TDP 665759IBA 01/2006

3	Therapeutics 01/2018 - 03/2008
1	Liver Transplantation 03/2014
1	Highly Active Antiretroviral Therapy (HAART) 08/2011